IDC reports drop in DR demand

Article

Gross revenues fell 16.6% for digital radiography vendor IDC in the third quarter compared to the year earlier period.

Gross revenues fell 16.6% for digital radiography vendor IDC in the third quarter compared to the year earlier period.  For the year, gross revenues were down 40.1% compared to the previous nine-month period. Executives blame the decline primarily on falling demand in the U.S.  Despite shrinking revenues, however, the company pared its net loss in 3Q to $1.5 million from a net loss of $2.7 in the previous year 3Q, an improvement achieved by belt tightening measures that cut the quarter’s expenses by 44.4% to $1.5 million. Commenting on the third quarter 2009 results, IDC President and CEO Tom Boon said the results were below expectations, but noted that the company is continuing to cut costs and improve management processes.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.